Spotlight Medical, a startup focusing on AI-driven prognosis tests for cancer treatment, has successfully raised €6.2 million in seed funding. The investment was led by Kurma Partners and Heal Capital, showcasing confidence in the company's innovative approach.
This funding will allow Spotlight Medical to introduce its first prognosis test to the clinic, a significant step in advancing AI-based solutions for cancer treatment. By utilizing patient treatment data, the company aims to improve treatment precision and outcomes, ensuring patients receive optimal care.
The Australian Financial Review 12month
Good Good Good on MSN.com 11month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
